Stryker Corporation (BMV:SYK)
7,164.03
0.00 (0.00%)
Last updated: Aug 11, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Instruments | 2.83B | Log In | Log In | Log In | Log In | Upgrade |
Instruments Growth | 9.44% | Log In | Log In | Log In | Log In | Upgrade |
Endoscopy | 3.39B | Log In | Log In | Log In | Log In | Upgrade |
Endoscopy Growth | 12.99% | Log In | Log In | Log In | Log In | Upgrade |
Medical | 3.85B | Log In | Log In | Log In | Log In | Upgrade |
Medical Growth | 11.16% | Log In | Log In | Log In | Log In | Upgrade |
Knees | 2.45B | Log In | Log In | Log In | Log In | Upgrade |
Knees Growth | 8.61% | Log In | Log In | Log In | Log In | Upgrade |
Hips | 1.70B | Log In | Log In | Log In | Log In | Upgrade |
Hips Growth | 12.21% | Log In | Log In | Log In | Log In | Upgrade |
Trauma and Extremities | 3.51B | Log In | Log In | Log In | Log In | Upgrade |
Trauma and Extremities Growth | 14.45% | Log In | Log In | Log In | Log In | Upgrade |
Spinal Implants | 707.00M | Log In | Log In | Log In | Log In | Upgrade |
Spinal Implants Growth | -19.49% | Log In | Log In | Log In | Log In | Upgrade |
Other Orthopaedics | 712.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Orthopaedics Growth | 6.93% | Log In | Log In | Log In | Log In | Upgrade |
Neurovascular | 1.31B | Log In | Log In | Log In | Log In | Upgrade |
Neurovascular Growth | 24.13% | Log In | Log In | Log In | Log In | Upgrade |
Neuro Cranial | 2.14B | Log In | Log In | Log In | Log In | Upgrade |
Neuro Cranial Growth | 17.19% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
MedSurg & Neurotechnology Operating Income | 4.00B | Log In | Log In | Log In | Log In | Upgrade |
MedSurg & Neurotechnology Operating Income Growth | 14.82% | Log In | Log In | Log In | Log In | Upgrade |
Orthopaedics Operating Income | 2.59B | Log In | Log In | Log In | Log In | Upgrade |
Orthopaedics Operating Income Growth | 16.38% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 16.94B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 12.39% | Log In | Log In | Log In | Log In | Upgrade |
International | 5.65B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | 8.31% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Organic Net Sales Growth | 10.20% | Log In | Log In | Log In | Log In | Upgrade |